Maxcyte is a biotechnology company that develops and manufactures cell therapies for the treatment of cancer and other diseases. The company's platform technology allows for the production of large quantities of high-quality cells that can be used in a variety of therapeutic applications. . The company's ExPERT™ platform, which is based on it's Flow Electroporation technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT™ family of products includes: four instruments, the ATx™, STx™, GTx™ and VLx ™; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio.